Showing results (1-10 of 432) with videos related to
Sort By:
Pageof 44
British Journal of Hospital Medicine (London, England : 2005)|May 1, 2007
New-onset diabetes after transplantationDavid C Wheeler, Andrew J KrentzExpert Opinion on Drug Safety|October 19, 2006
Comparative safety of newer oral antidiabetic drugsAndrew J KrentzMetabolic Syndrome and Related Disorders|March 29, 2008
Prevention of cardiovascular complications of the metabolic syndrome: focus on pharmacotherapyAndrew J KrentzCurrent Medical Research and Opinion|December 25, 2007
Management of type 2 diabetes in the obese patient: current concerns and emerging therapiesAndrew J KrentzDiabetes, Obesity & Metabolism|February 27, 2004
Lipoprotein abnormalities and their consequences for patients with type 2 diabetesAndrew J KrentzBiomarkers in Medicine|October 14, 2016
Glucose: archetypal biomarker in diabetes diagnosis, clinical management and researchAndrew J Krentz, Marcus HompeschFertility and Sterility|June 23, 2009
Reduced serum ghrelin in a putative postmenopausal polycystic ovary syndrome phenotypeAndrew J Krentz, Elizabeth Barrett-ConnorDrugs|January 27, 2005
Oral antidiabetic agents: current role in type 2 diabetes mellitusAndrew J Krentz, Clifford J BaileyDiabetes, Obesity & Metabolism|October 11, 2007
Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implicationsAndrew J Krentz, Geraldine Clough, Christopher D ByrneJournal of Vascular Research|July 3, 2009
Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?Andrew J Krentz, Geraldine Clough, Christopher D ByrnePageof 44